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Background: The path from subclinical psychotic experiences to clinical disorder is thought to be mediated by
the persistence of subclinical psychotic experiences. One of the factors that is likely associated with this
persistence is depression. Although commonly viewed as interrelated concepts, the exact relationship
between subclinical psychosis and depression is not clear.
Methods: Cross-lagged path modeling was used to explore the relationship between subclinical psychosis and
depression across and over time in an adolescent population seeking assistance for non-psychotic disorders
(N=138), measured at four occasions over a two-year period.
Results: Subclinical psychosis and depression were related to each other at every cross-sectional measurement,
but did not predict each other over time. Subclinical psychotic experiences and depressive symptom levels were
highest at baseline, when participants presented to the clinical service for help. In addition, the relationship
between them was also strongest at baseline and decreased signiﬁcantly over time.
Conclusion: The results suggest that psychosis and depression are interrelated phenomena that strongly co-occur
in time, but longitudinally, one does not predict change in the other. Both psychopathological dimensions should
be addressed when treatment is provided to adolescent help-seekers.
© 2011 Elsevier B.V. Open access under the Elsevier OA license. 1. Introduction
The extended psychosis phenotype is assumed to exist on a con-
tinuum, with many individuals endorsing psychotic experiences
below clinical signiﬁcance (van Os et al., 2009; Yung et al., 2009;
Nuevo et al., 2010). This view posits that psychotic experiences do not
inevitably result in psychotic disorder. However, for some individuals
with subclinical psychotic phenomena, disordermay develop depend-
ing on additional factors, such as secondary distress or intrusiveness,
psychopathological comorbidities or environmental inﬂuences. These
may cause subclinical psychotic experiences to become persistent
with subsequent impairment and need for care, consistent with thehic Experiences; CES-D, Centre
m Likelihood; CFI, Comparative
tion.
linary Social Science Faculty of
Box 80.140 Heidelberglaan 2,
8; fax: +31 30 253 4733.
n).
vier OA license. proneness–persistence–impairment model of psychosis (Cougnard
et al., 2007).
One of the factors that may play a role in the process of shifting
along the psychosis continuum may be depression (Yung, 2007; van
Rossumet al., 2009). Depression and positive psychosis are considered
separate but interrelateddimensions of psychotic disorder (vanOs and
Kapur, 2009) and are closely related on all levels of the continuum.
Clinically, this is reﬂected by diagnoses such as schizoaffective ormood
disorders with psychotic features, in which depressive and psychotic
symptoms co-occur. Furthermore, comorbidity between schizophre-
nia and depression is very high; up to 50% of schizophrenia patients
experience comorbid depression (Buckley et al., 2009). In the earlier
phases of psychotic illness, depression is a commonly reported symp-
tom in the prodrome (Häfner et al., 2005; Iyer et al., 2008) and has
been shown to predict transition from ultra-high risk status to frank
psychosis (Yung et al., 1998, 2003, 2004). Further down the psychosis
continuum, subclinical psychotic symptoms and depression are
associated in adolescent (Armando et al., 2010; Mackie et al., 2011;
Yung et al., 2006; Wigman et al., in press) and adult (Krabbendam
et al., 2005a) general population samples. From a longitudinal
perspective, data from general population samples show that the
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symptoms in a dose–response fashion over time (Yung, 2007;Wigman
et al., in press). Additionally, the presence of depressive symptoms in
combination with hallucinatory experiences increases the risk for a
later diagnosis of clinical psychosis (Krabbendam et al., 2005b).
Although psychosis and depression often co-occur at clinical and
subclinical levels, the exact nature of their relationship is unclear.
Depression could directly impact psychotic symptoms (van Rossum
et al., 2009) by inducing negative appraisal of external stimuli,
subsequently increasing psychotic symptoms (Freeman et al., 2001)
and risk for clinical disorder (Yung et al., 2004). Conversely, experienc-
ing psychotic symptoms may induce feelings of fear, hopelessness and
depression (Krabbendam et al., 2005a). Other theories suggest that
psychosis anddepression exist on the samecontinuum, in thatbothmay
result from shared liability (Verdoux et al., 1999). More research is
needed to elucidate this complex relationship further.
1.1. Aims
The current study aimed to investigate the co-occurrence of, and
directional relationship between, subclinical psychosis and depres-
sion, across and over time. We investigated this association in an
adolescent sample seeking help for general, non-psychotic psycho-
pathology. The dynamic adolescent life phase is an interesting period
for studying this association, since proneness for both psychosis
(Verdoux et al., 1998) and depression (Costello et al., 2003) are at
their peak. Subclinical psychotic experiences were assessed with the
Community Assessment of Psychic Experiences (CAPE) and depres-
sive symptoms with the Centre for Epidemiologic Studies Depression
Scale (CES-D) questionnaires. Cross-lagged path modeling, a statisti-
cal method that enables the investigation of the longitudinal and
directional nature of associations, was applied in the present study.
Based on evidence for a causal relationship in both directions, it was
hypothesized that subclinical psychotic experiences and depressive
symptoms would predict each other in and across time.
2. Method
2.1. The setting
Orygen Youth Health (OYH) is a public mental health program for
young people between 15 and 24 years old. The catchment area of
north and west metropolitan Melbourne, Australia, covers approxi-
mately 900,000 people, about 200,000 of whom are aged between 15
and 24. The service provided at OYH has three components: EPPIC
(Early Psychosis Prevention and Intervention Centre), which is a
service for people with ﬁrst-episode psychotic disorder, the PACE
(Personal Assessment and Crisis Evaluation) clinic, which targets
individuals at ultra-high risk of psychosis, and Youthscope, a service
for non-psychotic individuals.
Referrals to OYH are taken from a range of sources, including
general practitioners (GPs) and other primary care services, school and
university counseling services, drug and alcohol services, the justice
system, and youth accommodation centres, as well as from families
and young people themselves. The procedure for entry into OYH is as
follows: ﬁrst, a brief telephone “triage” interview is undertaken with
the referrer and the young person. Once basic criteria are met (i.e. age
and location), the young person is referred to one of the three clinical
teams (EPPIC, PACE, or Youthscope) for a face-to-face interview to
determine eligibility and symptom proﬁle. All young people who are
recognized as meeting the criteria for EPPIC and PACE at this inter-
view are accepted. However, because of the high prevalence of
non-psychotic disorders such as depression, there are many more
young people referred to Youthscope than can be accepted. Thus,
criteria have been established for acceptance into Youthscope. These
are based largely on presence of a diagnosis of a non-psychotic mentaldisorder, such as depression, anxiety, and/or severe personality
disorder. Degree of risk of suicide or self-harm, disability or functional
impairment, and previous history of unsuccessful treatment within
primary care services are also taken into account by the Youthscope
clinician. Many young people not accepted into Youthscope also have
high rates of depressive symptoms and poor functioning. Those not
accepted also include young people with a primary diagnosis of an
uncomplicated substance use disorder or a primary diagnosis of
oppositional deﬁant disorder. The study group for this project was
taken from those who were referred to, but not necessarily accepted
into, Youthscope.
2.2. Participants
Two hundred and four young people (aged 15–24 years) referred
to Youthscope between April and October 2003 were invited to
participate. Exclusion criteria were: known organic cause for
presentation, known intellectual disability (IQb70), and inability to
speak English. The overall participation rate was 72.5% (56 refusals).
At baseline, 138 participants completed both the CAPE and CES-D. This
is the sample included in the current analysis. The mean age was 17.7
(SD 2.6); 58% of the sample was female.
A full description of the psychiatric diagnoses of this cohort,
assessed with the Structured Clinical Interview for DSM-IV (SCID;
First et al., 1997), is described by Godfrey et al. (2005). Brieﬂy, 46%
had current major depressive disorder, 63% had an anxiety disorder
and 27% had a substance use disorder. The most common comorbidity
was mood and anxiety disorders, followed by substance use disorders
in combination with other mental disorders, particularly mood and
anxiety disorders (Godfrey et al., 2005).
2.3. Procedure
Data were collected at four assessments: at T1 (baseline; N=138);
at T2, (3 months after baseline; N=116, 84.1% of original cohort); at T3
(6 months after baseline; N=113, 81.9% of original sample); and at T4
(2 years after baseline; N=99, 71.7% of original sample). The studywas
approved by the local Research and Ethics Committee.
2.4. Instruments
The Community Assessment of Psychic Experiences (CAPE) positive
experiences subscale (20 self-report items)wasused to assess psychotic
experiences (Stefanis et al., 2002; Konings et al., 2006). The CAPE is
based on the Peters et al. Delusions Inventory (Peters et al., 1999) (PDI),
modiﬁed to also include hallucinatory experiences. Each item in the
CAPE rates (i) frequency and (ii) associated distress on a four-point
scale. The frequency items showed good internal consistency at all time
points (Cronbach's alpha: 0.86–0.91). The Centre for Epidemiologic
Studies Depression Scale (CES-D) (20 self-report items) was used to
assess depressive symptomatology in the past week (Radloff, 1977).
This measure rates frequency of symptoms on a four-point scale. The
CES-D has been validated in an Australian adolescent sample (Rey et al.,
2001). Themeasure showed good internal consistency at all time points
(Cronbach's alpha: 0.78–0.98). Sum scores of both questionnaires were
used as continuous indicators with higher scores indicate greater
psychopathology.
2.5. Analysis
Analyses were conducted with Mplus 5.1 (Muthén and Muthén,
1998–2007) and PASWStatistics 18 (SPSS Inc., Chicago, Illinois, 2010).
Drop-out analyses were conducted using ANOVA and odd ratios (OR).
Time effects of CAPE and CES-D scores were tested with Repeated
Measures ANOVA.
Table 1
Means (SD) of the CAPE and CES-D at all four time points.
T1 T2 T3 T4
Baseline 3 months 6 months 24 months
CAPE—positive experiences 31.0 (9.0) 27.1 (7.4) 25.6 (7.5) 26.5 (8.2)
CES-D—depressive symptoms 28.9 (13.7) 23.0 (14.4) 20.2 (13.5) 18.1 (13.1)
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CAPE and CES-D scores over time, using only observed variables. Full
InformationMaximumLikelihoodestimationwasused formissingdata;
furthermore, robust ML (MLR) was used for model estimation because
data was not normally distributed. This method estimates mean-
adjusted χ2, robust to non-normality (Brown, 2006). Over time, CAPE
scores were regressed on (i) earlier CAPE scores and (ii) earlier CES-D
scores and vice versa. CAPE and CES-D scores were allowed to correlate
at all time points; correlations were compared with Wald tests. Thus, a
cross-lagged path model was established. CAPE and CES-D scores at T1
were controlled for age and gender.
Several ﬁt indices were used for model evaluation (Brown, 2006).
For acceptable model ﬁt, chi-square (χ2) should be low, Comparative
Fix Index (CFI) should be above 0.90 and Root Mean Square Error of
Approximation (RMSEA) should be lower than 0.08.
3. Results
3.1. Descriptives
There were no signiﬁcant differences between participants who
completed all study phases and those who dropped out after T1 on
age, gender, socio-economic status, or CES-D and CAPE scores at
baseline. Table 1 shows mean scores (SD) of the CAPE and CES-D at
the four time points. Both CAPE [F(3,171)=14,75; pb .001] and CES-D
[F(3,216)=166,66; pb .001) scores decreased signiﬁcantly over time.
Between T1 and T4, CES-D scores decreased by 37.5%, while CAPE
scores decreased by 14.5%. The proportion decrease in CES-D scores
was signiﬁcantly greater than that of CAPE scores (OR=0.29, 95%
CI=0.081–0.995, p=0.049).
3.2. Model development
The model is depicted in Fig. 1. A model with all paths ﬁt the data
reasonably: χ2(24) = 51.58; p b .0001; CFI=0.903 and
RMSEA=0.089. When non-signiﬁcant paths were removed, model
ﬁt improved and both CFI and RMSEA were acceptable (χ2(30)=
55.487; pb .003; CFI=0.910; RMSEA=0.075).
CES-D and CAPE scores were signiﬁcantly and substantially
correlated at all assessments (pb .001). The correlation decreasedFig. 1. Path model of subclinical positive psychotic experiences and depressive symptoms
Effect sizes are given in beta's.signiﬁcantly between T1 and T2 (F(1)=6.06; pb .01), but not between
other assessments. CAPE scores were signiﬁcantly predicted by earlier
CAPE scores (β 0.61–0.73). CES-D scoreswere signiﬁcantly predicted by
earlier CES-D scores (β 0.47–0.62). CAPE scoreswere never predicted by
earlier CES-D scores, nor predicted CES-D scores over time. Effect sizes
are reported in beta's, with a betab0.10 representing a small effect, a
beta of 0.10–0.30 a moderate effect and a beta N0.50 a large effect.4. Discussion
The present study investigated the direction and nature of the
relationship between subclinical psychotic experiences and depres-
sive symptoms across and over time in an adolescent population
which were help-seeking for general, non-psychotic psychopatholo-
gy. Subclinical psychosis and depression were closely related at every
assessment, but did not predict each other over time. The relationship
was strongest at baseline, when participants presented to the service,
and decreased signiﬁcantly over time.
These results do not support the hypothesized longitudinal
bidirectional relationship between subclinical psychosis and depres-
sion (van Rossum et al., 2009; Krabbendam et al., 2005a). Rather,
results suggest that subclinical psychotic experiences and depression
are interwoven phenomena that co-occur, but do not predict one
another over time. However, this does not rule out the possibility of
concurrent causation; that is, the notion that subclinical psychotic
experiences and depression may exist as expressions of interrelated,
yet distinguishable aspects of the same underlying factor.
The ﬁnding is consistent with suggestions that levels of depression
mirror, almost exactly, levels of subclinical psychotic experiences in the
general population (Yung et al., 2009; Wigman et al., in press). Van Os
and Kapur (2009) suggest that psychosis consists of multiple domains
(positive, negative, cognitive and affective symptoms). The present
ﬁndings support this by demonstrating that depression and psychosis
exist as parallel and comorbid phenomena, but changing relatively
distinguishably of one another. Other researchers have posited that
psychosis and depression share a common liability (Verdoux et al.,
1999) or common risk factors (Stefanis et al., 2002). These hypotheses
are supported by previous ﬁndings in the general population. Using
both self-report (Stefanis et al., 2002) and clinical interview data
(Krabbendam et al., 2004), subclinical psychosis and depression have
been shown to exist as separate but correlated dimensions.
In the current study, depressive symptoms decreasedmore strongly
over time than subclinical positive psychotic experiences. This may be
explained by the fact that participants were referred to Youthscope for
non-psychotic disorders (e.g., depression and anxiety). Treatment is
likely to have been focused on reducingmood-related symptoms rather
than subclinical psychotic experiences, leading depressive symptoms to
improve more. The highest correlation between subclinical psychosis. Note: only signiﬁcant paths are depicted. Model was controlled for age and gender.
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relationship decreased, although the two are always signiﬁcantly
correlated. This decrease cannot be ascribed as inherent to the path
model (i.e. that correlations at later time points are lower because these
associations are more strongly controlled for), since the individual
correlations also decreased over time (data not shown). This is a classic
example of Berkson's bias; the phenomenon that two psychopatholog-
ical dimensions are more highly correlated in clinical samples than at
the general population level (Boccia et al., 2007).
The present ﬁndings should be interpreted in light of the strengths
andweaknesses of the study. These results are important because they
suggest that, over time, changes in one of these dimensions do not
appear to lead to changes in the other, at least at this subclinical stage
of the psychosis continuum. Self-report questionnaires were used for
collecting data. Thismethodmay lead to data loss compared to clinical
interviews, but several studies have shown that it is a reliable method
to assess subclinical psychotic experiences (Allardyce et al., 2007;
Kelleher et al., 2011). The fact that the sample is help-seeking can be
either an advantage or a disadvantage. The interesting ﬁnding that the
relationship between subclinical psychosis and depression was
strongest at the moment of presentation and decreased over time
would have been impossible to ﬁnd in a general population sample.
However, because of the nature of this sample, the results may not be
generalizable to psychotic, UHR or general population samples. Future
research should aim at replicating the ﬁndings in different samples to
fully understand the complex relations between these two concepts,
since the dynamics between psychosis and depression may differ
along the psychosis phenotype. It is also necessary to better
understand other factors that may mediate the relationship.
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